Chinese Drugmakers Adopt AI Apps for Doctor Outreach Amid Marketing Crackdown

Chinese pharmaceutical companies are increasingly using AI-powered apps from platforms like Alibaba Health and JD Health to engage with doctors. This strategic shift follows heightened scrutiny from Beijing on traditional hospital visit-based marketing, which disrupted conventional outreach methods. The move creates new revenue streams for health-tech firms and reshapes pharmaceutical marketing practices in China.